IP Library Granted Patent US 9,861,586
Granted Patent B2
US 9,861,586 · App. 15/590,369 · Granted Jan 9, 2018

Chewable soft capsules

Inventors: EmadEldin M. Hassan (Parkton, MD); Warren Walter Kindt (Ossineke, MI); Roger E. Gordon (Stokesdale, NC)
Assignee: Patheon Softgels, LLC
A61K9/4816A61K9/0056A61K9/4825A61K9/4858A61K9/4866A61K31/135A61K31/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,586
App. No.
15/590,369
Granted
Jan 9, 2018
Kind
B2
Abstract

A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.

Claims (60)

1. A soft capsule suitable for chewing or buccal dissolution comprising a sheath encapsulating a flowable matrix,

the sheath comprising:

at least one polymer;

at least one plasticizer;

at least one first sweetener;

at least one polymer modifier;

water; and

the flowable matrix comprising:

at least one hydrophilic polymer;

at least one flavoring agent;

at least one second sweetener;

at least one active ingredient; and

water.

2. The soft capsule of claim 1 , wherein the polymer comprises gelatin, partially hydrolyzed gelatin, hydrolyzed gelatin, or a combination thereof.

3. The soft capsule of claim 1 , wherein the plasticizer comprises maltitol, glycerin, xylitol, or a combination thereof.

4. The soft capsule of claim 1 , wherein the polymer modifier comprises a carboxylic acid.

5. The soft capsule of claim 1 , wherein the polymer modifier comprises citric acid, lactic acid, tartaric acid, fumaric acid, glycolic acid, or a combination thereof.

6. The soft capsule of claim 1 , wherein the polymer modifier comprises citric acid.

7. The soft capsule of claim 1 , wherein the active ingredient comprises therapeutic, diagnostic, or nutritional agents.

8. The soft capsule of claim 1 , wherein the sheath comprises:

about 32% by weight of at least one polymer;

about 40% by weight of at least one plasticizer;

about 0.2% by weight of at least one sweetener;

about 0.5% by weight of at least one polymer modifier; and

about 23% by weight water; and

the flowable matrix comprises:

about 5% by weight water; and

about 1.5% by weight of at least one active ingredient.

9. A soft capsule suitable for chewing or buccal dissolution comprising a sheath encapsulating a flowable matrix,

the sheath comprising:

at least one polymer;

at least one plasticizer;

at least one first sweetener;

at least one first polymer modifier;

at least one colorant; and

water; and

the flowable matrix comprising:

at least one hydrophilic polymer;

at least one second polymer modifier;

at least one second sweetener;

at least one taste masking agent;

water; and

at least one active ingredient.

10. The soft capsule of claim 9 , wherein the polymer comprises gelatin, partially hydrolyzed gelatin, hydrolyzed gelatin, or a combination thereof.

11. The soft capsule of claim 9 , wherein the plasticizer comprises maltitol, glycerin, xylitol or a combination thereof.

12. The soft capsule of claim 9 , wherein the first and second polymer modifiers comprise a carboxylic acid.

13. The soft capsule of claim 9 , wherein the first and second polymer modifier comprises citric acid, lactic acid, tartaric acid, fumaric acid, glycolic acid, or a combination thereof.

14. The soft capsule of claim 9 , wherein the first and second polymer modifier comprises citric acid.

15. The soft capsule of claim 9 , wherein the second sweetener comprises sucralose.

16. The soft capsule of claim 9 , wherein the active ingredient comprises therapeutic, diagnostic, or nutritional agents.

17. The soft capsule of claim 9 , wherein the flowable matrix comprises:

about 2% by weight polymer modifier;

about 20% by weight water;

about 7% by weight active ingredient.

18. The soft capsule of claim 9 , wherein the combined composition of the sheath and matrix comprises:

about 15% by weight total polymer;

about 10% by weight total plasticizer;

about 2% by weight total polymer modifier;

about 20% by weight total water; and

about 7% by weight active ingredient.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
Continuity (6)
Continuation 14790624 · Jul 2, 2015
Continuation 14316831 · Jun 27, 2014
Continuation 13327293 · Dec 15, 2011
Division 10512318
Provisional Application 60375479 · Apr 25, 2002
Related Publication 20170239188A1 · Aug 24, 2017